Friday, September 17, 2021
Home National Sputnik Light vaccine gets DCGI nod for third phase trials

Sputnik Light vaccine gets DCGI nod for third phase trials

The Drugs Controller General of India (DCGI) has given permission for the Phase III trial of Russia’s Sputnik Light Vaccine in the country. Sputnik Light is a single dose vaccine used against COVID-19. This approval has been given after a recent study published in the medical journal ‘The Lancet’. It has been found in this study that Sputnik Light has shown an efficacy of 78.6% to 83.7% against COVID-19, which is much higher than most two-dose vaccines. In July, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) had refused to approve the emergency use of Sputnik Light.

Read more: India.com | India Today | Business Today

Report Post

Avantika Yadav
23, Content Editor @HeadlineEnglish @HeadlineHindi

TRENDING NEWS

LATEST NEWS